PhRMA Priorities Include Insurance Advocacy And Public Education On Patent Issues

The association’s incoming chair, Bristol CEO Peter Dolan, is launching a five-year planning process.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet